Company Profile: TcLand Expression.

ABSTRACT

TcLand Expression is a fully integrated molecular diagnostics company that holds a pioneering position in personalized medicine focusing on immunology (transplantation and autoimmune disorders). The company has a well-balanced pipeline of blood-based gene-expression biomarkers and companion diagnostics in development. The company's state-of-the-art central laboratories are International Organization for Standardization (ISO) 17025-accredited for quantitative PCR. TcLand Expression has expertise in all the steps of biomarker development, from research and development, bioinformatics and biostatistics to clinical and regulatory affairs, market access and production. Through gene-set discovery, external and clinical validation in large multinational studies, TcLand Expression is developing diagnostic and prognostic blood tests to help make personalized medicine a reality for transplant recipients and patients with autoimmune diseases.